Leucemia mielomonocítica crónica

Leucemia mielomonocítica crónica

La leucemia mielomonocítica crónica es un desorden clonal de las células progenitoras hematopoyéticas clasificado como neoplasia mielodisplásica mieloproliferativa. Se caracteriza por la presencia de monocitosis absoluta y persistente en la sangre periférica (> 1.0 x 10 9/L) con la presencia de d...

Full description

Bibliographic Details
Main Authors:	Yamilé Quintero-Sierra, Gelquin L Mustelier-Celza, Carlos Hernández-Padrón, Adrián Romero-González
Format:	Article
Language:	Spanish
Published:	Editorial Ciencias Médicas
Series:	Revista Cubana de Hematología, Inmunología y Hemoterapia
Subjects:	chronic myelomonocytic leukemia myelodysplastic/myeloproliferative neoplasm
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000400002&lng=en&tlng=en

Similar Items

Infiltración extramedular en la leucemia mielomonocítica crónica (LMMC) Extramedullary infiltration in chronic myelomonocytic leukemia (CMML)
by: Onel Ávila Cabrera
Published: (2008-12-01)

AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.
by: Pasquale Niscola
Published: (2014-02-01)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
by: I. N. Subortseva, et al.
Published: (2017-01-01)

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
by: Elena Elli, et al.
Published: (2012-03-01)

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
by: Elena Elli, et al.
Published: (2012-01-01)

Leucemia Mieloide Crónica en un paciente con anemia drepanocítica
by: Yamilé Quintero-Sierra, et al.

Concurrent juvenile myelomonocytic leukemia with thalassemia in a case with Plasmodium knowlesi infection from Sabah, Malaysian Borneo
by: Mimi Azreen Abdullah, et al.
Published: (2019-06-01)

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies
by: Uwe Platzbecker, et al.
Published: (2022-05-01)

Clinico-hematological and Cytogenetic Study of Myeloid Neoplasms: A cross-sectional Study from South India
by: Nidhi Nair, et al.
Published: (2025-01-01)

Unusual transformation from refractory anemia to chronic myelomonocytic leukemia: a case report.
by: Pasquale Niscola
Published: (2014-08-01)

CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis
by: Xinmin Zhang, et al.
Published: (2022-01-01)

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group
by: Krzysztof Mądry, et al.
Published: (2024-06-01)

Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes
by: Vincent Jachiet, et al.
Published: (2021-05-01)

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients
by: Ludan Zhang, et al.
Published: (2024-05-01)

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia
by: Jill A. Bell, et al.
Published: (2019-06-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
by: E.D.R.P. Velloso, et al.
Published: (2013-01-01)

Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia
by: Müfide Okay, et al.
Published: (2019-08-01)

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01)

Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report
by: Moqin Jiang, et al.
Published: (2024-07-01)

ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes
by: Xia Wu, et al.
Published: (2020-07-01)

Leucemia mielomonocítica aguda y drepanocitosis no tratada con hidroxiurea: A propósito de un caso
by: Anadely Gámez Pérez, et al.
Published: (2009-06-01)

Landscape of biallelic DNMT3A mutant myeloid neoplasms
by: Naomi Kawashima, et al.
Published: (2024-09-01)

A Case of Chronic Myelomonocytic Leukemia: the Onset of which was Manifestedby Hypokalemia and Hypocalcemia
by: HAN Weimin, et al.
Published: (2022-10-01)

Leucemia Cutis de presentación atípica An atypical presentation of Leukemia Cutis
by: F Pulgar Martín, et al.
Published: (2011-06-01)

Efficacy and Safety of Hypomethylating Agents in Chronic Myelomonocytic Leukemia: A Single-Arm Meta-analysis
by: Xinhui Zheng, et al.
Published: (2022-06-01)

Genetic mutations associated with blood count abnormalities in myeloid neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01)

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment
by: Argiris Symeonidis, et al.
Published: (2023-03-01)

Chronic Myelomonocytic Leukemia: Hematopathology Perspective
by: Siba El Hussein, et al.
Published: (2021-08-01)

Dacogen administration experience for treatment of patients with myelodisplastic syndrome and chronic myelomonocytic leukemia
by: S. V. Gritzaev, et al.
Published: (2022-11-01)

Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
by: Marie-Camille Lafargue, et al.
Published: (2023-12-01)

Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
by: Priyanka Moule, et al.
Published: (2023-01-01)

The sweet symphony of N-glycans in myeloid malignancies
by: Javier Sanmartín-Martínez, et al.
Published: (2024-07-01)

Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia
by: Mert Öztaş, et al.
Published: (2021-08-01)

Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada
by: John Paul Yun, et al.
Published: (2023-08-01)

The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies
by: Hans Felix Staehle, et al.
Published: (2021-12-01)

A clinical case of extramedullary skin lesion in a patient with acute myelomonocytic leukemia
by: G. S. Safuanova, et al.
Published: (2022-04-01)

Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report
by: Clémence Haméon, et al.
Published: (2023-08-01)

Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia
by: Luka Čemažar, et al.
Published: (2020-12-01)

Erythroderma in a patient with chronic myelomonocytic leukemia
by: Nicole Trepanowski, BS, et al.
Published: (2022-08-01)